Imanol González Burguera

Dr. Imanol González Burguera


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MSMiquel Saumell
Miquel Saumell
DDDiego Delgado
Diego Delgado
GCGontzal García del Caño
Gontzal García del Caño
MBMaider Beitia
Maider Beitia
JSJoan Sallés
Joan Sallés
MSMikel Sánchez
Mikel Sánchez
Platelet-Rich Plasma (PRP) is enriched in molecular messengers with restorative effects on altered tissue environments. Upon activation, platelets release a plethora of growth factors and cytokines, either in free form or encapsulated in exosomes, which have been proven to promote tissue repair and regeneration. Translational research on the potential of exosomes as a safe nanosystem for therapeutic cargo delivery requires standardizing exosome isolation methods along with their molecular and morphological characterization. With this aim, we isolated and characterized the exosomes released by human PRP platelets. Western blot analysis revealed that CaCl2-activated platelets (PLT-Exos-Ca2+) released more exosomes than non-activated ones (PLT-Exos). Moreover, PLT-Exos-Ca2+ exhibited a molecular signature that meets the most up-to-date biochemical criteria for platelet-derived exosomes and possessed morphological features typical of exosomes as assessed by transmission electron microscopy. Array analysis of 105 analytes including growth factors and cytokines showed that PLT-Exos-Ca2+ exhibited lower levels of most analytes compared to PLT-Exos, but relatively higher levels of those consistently validated as components of the protein cargo of platelet exosomes. In summary, the present study provides new insights into the molecular composition of human platelet-derived exosomes and validates a method for isolating highly pure platelet exosomes as a basis for future preclinical studies in regenerative medicine and drug delivery.

1 January 2014 in Advances in Biological Regulation
Verified
Journal Article
Closed access
GCGontzal García del Caño
Gontzal García del Caño
MMMario Montaña
Mario Montaña
XAXabier Aretxabala
Xabier Aretxabala
IBImanol González Burguera
Imanol González Burguera
MJMaider López de Jesús
Maider López de Jesús
JSJoan Sallés
Joan Sallés

1 October 2012 in Neuroscience
Verified
Journal Article
Closed access
MMM. Montaña
M. Montaña
GCGontzal García del Caño
Gontzal García del Caño
MJM. López de Jesús
M. López de Jesús
IBImanol González Burguera
Imanol González Burguera
LEL. Echeazarra
L. Echeazarra
JSJoan Sallés
Joan Sallés

Verified
Journal Article
Open access
PDF file
DDDiego Delgado
Diego Delgado
ABAne Miren Bilbao
Ane Miren Bilbao
MBMaider Beitia
Maider Beitia
AGAne Garate
Ane Garate
PSPello Sánchez
Pello Sánchez
MSMikel Sánchez
Mikel Sánchez
Platelet-rich plasma (PRP) is a biologic therapy that promotes healing responses across multiple medical fields, including the central nervous system (CNS). The efficacy of this therapy depends on several factors such as the donor’s health status and age. This work aims to prove the effect of PRP on cellular models of the CNS, considering the differences between PRP from young and elderly donors. Two different PRP pools were prepared from donors 65–85 and 20–25 years old. The cellular and molecular composition of both PRPs were analyzed. Subsequently, the cellular response was evaluated in CNS in vitro models, studying proliferation, neurogenesis, synaptogenesis, and inflammation. While no differences in the cellular composition of PRPs were found, the molecular composition of the Young PRP showed lower levels of inflammatory molecules such as CCL-11, as well as the presence of other factors not found in Aged PRP (GDF-11). Although both PRPs had effects in terms of reducing neural progenitor cell apoptosis, stabilizing neuronal synapses, and decreasing inflammation in the microglia, the effect of the Young PRP was more pronounced. In conclusion, the molecular composition of the PRP, conditioned by the age of the donors, affects the magnitude of the biological response.

5 October 2015 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
MAMireia Agirre
Mireia Agirre
EOEdilberto Ojeda
Edilberto Ojeda
JZJon Zarate
Jon Zarate
GPGustavo Puras
Gustavo Puras
SGSantiago Grijalvo
Santiago Grijalvo
José Luis PedrazJosé Luis Pedraz
José Luis Pedraz

1 May 2016 in Advances in Biological Regulation
Verified
Journal Article
Closed access
Suzanne ScarlataSuzanne Scarlata
Suzanne Scarlata
OGOsama Garwain
Osama Garwain
LWLeo Williams
Leo Williams
IBImanol González Burguera
Imanol González Burguera
BRBarbara Rosati
Barbara Rosati
UGUrszula Golebiewska
Urszula Golebiewska